2012
DOI: 10.1002/polb.23056
|View full text |Cite
|
Sign up to set email alerts
|

Ultra low density and highly crosslinked biocompatible shape memory polyurethane foams

Abstract: We report the development of highly chemically crosslinked, ultra low density (~0.015 g/cc) polyurethane shape memory foams synthesized from symmetrical, low molecular weight and branched hydroxyl monomers. Sharp single glass transitions (Tg) customizable in the functional range of 45–70 °C were achieved. Thermomechanical testing confirmed shape memory behavior with 97–98% shape recovery over repeated cycles, a glassy storage modulus of 200–300 kPa and recovery stresses of 5–15 kPa. Shape holding tests under c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

12
183
3

Year Published

2014
2014
2020
2020

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 120 publications
(198 citation statements)
references
References 49 publications
12
183
3
Order By: Relevance
“…Increasing TEA percentage of the material decrease the T g , while increasing HPED percentage results in increased T g , along with greater crosslink density, higher elastic modulus, and greater hydrophobicity (HH100 contact angle of 77.0 ± 0.6°, HH0 contact angle of 61.3 ± 1.2°, TMH0 contact angle of 84.5 ± 0.5°, and IP/TMH0 97.3 ± 0.4°), results which are better detailed elsewhere [22,25]. These same trends will occur as the diisocyanate is changed from HDI to THMDI to IPDI, in increasing order of modulus, thermal transition, and hydrophobicity.…”
Section: Resultsmentioning
confidence: 85%
See 2 more Smart Citations
“…Increasing TEA percentage of the material decrease the T g , while increasing HPED percentage results in increased T g , along with greater crosslink density, higher elastic modulus, and greater hydrophobicity (HH100 contact angle of 77.0 ± 0.6°, HH0 contact angle of 61.3 ± 1.2°, TMH0 contact angle of 84.5 ± 0.5°, and IP/TMH0 97.3 ± 0.4°), results which are better detailed elsewhere [22,25]. These same trends will occur as the diisocyanate is changed from HDI to THMDI to IPDI, in increasing order of modulus, thermal transition, and hydrophobicity.…”
Section: Resultsmentioning
confidence: 85%
“…Substitution of the diisocyanates or alcohols does not affect gel fraction of the materials (all greater than 98%). Porosity and pore size of the SMPs can be partially controlled through a combination of NCO index, premix viscosity, catalyst concentrations, and concentration of physical blowing agents that are used, as demonstrated by Singhal et al [25]. By removing the catalysts and blowing agents, non-porous films were produced; decreasing premix viscosity and NCO index results in larger pore sizes and reduced densities of the SMPs [22].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…[18] Therapeutic embolization entails deliberately blocking a blood vessel (e.g., clipping an aneurysm to prevent internal bleeding, or reducing/stopping blood flow to tumors), and body temperature-responsive poly(ether urethane) SMP-based foams have been shown to be cytocompatible and enable the infiltration of mouse L929 fibroblast cells in vitro which is promising for potential future applications as aneurysm fillers in vivo. [19] Different temperature-responsive polyurethane SMPs that responded to temperature by expanding up to 70 times their original volume were shown to be relatively non-immunogenic in vitro [20] and after 90 days of implantation of radio-opaque analogues in a pig aneurysm model these materials showed low inflammation and good healing responses. [21] 3.…”
Section: Research Newsmentioning
confidence: 99%
“…SMP foams are materials capable of maintaining a temporary shape and, upon application of a thermal, chemical, or optical stimulus, recovering their primary shape [6]. These materials possess tunable thermal and mechanical properties [7][8][9] and are deliverable via catheter [10]. Other potential applications of SMP foams include peripheral vascular occlusion for disease treatment.…”
Section: Introductionmentioning
confidence: 99%